H. Uehleke

发表

Spectral evidence for 2,2,3-trichloro-oxirane formation during microsomal trichloroethylene oxidation

D. Henschler, G. Bonse, H. Uehleke, 1977, Archives of Toxicology.

The formation and kinetics of reactive drug metabolites in mammals.

H. Uehleke, 1974, Mutation research.

Thresholds in Acute and Long Term Animal Studies

H. Uehleke, 1983 .

The effects of 2,2 diethylallylacetamide on hepatic cytochromes in rats and in vitro

H. Uehleke, M. Brinkschulte-Freitas, 1978, Archives of Toxicology.

Oral toxicity of an essential oil from myrtle and adaptive liver stimulation.

H. Uehleke, M. Brinkschulte-Freitas, 1979, Toxicology.

Binding of 14 C-carbon tetrachloride to microsomal proteins in vitro and formation of CHC1 3 by reduced liver microsomes.

K. Hellmer, H. Uehleke, S. Tabarelli, 1973, Xenobiotica; the fate of foreign compounds in biological systems.

A comparative study on the irreversible binding of labeled halothane trichlorofluoromethane, chloroform, and carbon tetrachloride to hepatic protein and lipids in vitro and in vivo

H. Uehleke, T. Werner, Prof. Dr. H. Uehleke, 1975, Archives of Toxicology.

CRITICAL REVIEW OF EVALUATION OF TOXICOLOGICAL DATA BIOCHEMICAL PARAMETERS

H. Uehleke, 1977 .

The role of cytochrome P-450 in the N-oxidation of individual amines.

H. Uehleke, 1973, Drug metabolism and disposition: the biological fate of chemicals.

Covalent binding of CCl4-intermediates to reduced pyridine nucleotides in mouse liver.

M. Schwarz, W. Kunz, D. Kitta, 1981, Advances in experimental medicine and biology.

Binding of Haloalkanes to Liver Microsomes

H. Uehleke, 1977 .

[How safe is safe].

H. Uehleke, 2005, European journal of drug metabolism and pharmacokinetics.

N-hydroxylation of arylamines by bladder mucosa.

H. Uehleke, 1966, Life sciences.

Increased metabolic N-oxidation of 2-naphthylamine in dogs after phenobarbital pretreatment.

H. Uehleke, E. Brill, 1968, Biochemical pharmacology.

N-Hydroxylation of carcinogenic amines in vivo and in vitro with liver microsomes.

H. Uehleke, 1963, Biochemical pharmacology.

Irreversible binding of 3-14C-antipyrine to hepatic protein in vivo and in metabolizing liver microsomes

H. Uehleke, S. Tabarelli-Poplawski, 1977, Naunyn-Schmiedeberg's Archives of Pharmacology.

71 Relations between structure, velocity of biological N-hydroxylation and toxicity of aromatic amines

H. Uehleke, 1961 .

N-hydroxylation of 4,4′-diaminodiphenylsulphone (Dapsone) by liver microsomes, and in dogs and humans

H. Uehleke, S. Tabarelli, 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

N-hydroxylation of 4,4'-diaminodiphenylsulphone in liver microsomes and in vivo.

H. Uehleke, S. Tabarelli, 1971, Xenobiotica; the fate of foreign compounds in biological systems.

[Binding of carbon tetrachloride to reduced microsomal cytochrome P-450 and to heme].

H. Uehleke, O. Reiner, 1971, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

[Toxicological aspects of the N-hydroxylation of aromatic amines].

H. Uehleke, 1969, Naunyn-Schmiedebergs Archiv fur experimentelle Pathologie und Pharmakologie.

[Hydroxylamino- and nitrosobiphenyl: biological oxidation products of 4-aminobiphenyl and intermediates of 4-nitrobiphenyl reduction].

H. Uehleke, K. Nestel, 1967, Naunyn-Schmiedebergs Archiv fur experimentelle Pathologie und Pharmakologie.

[Methemoglobin formation by sulfonamides in a system containing liver homogenates, erythrocytes, NADPH and oxygen].

R. Thauer, H. Uehleke, A. Meiforth, 1965, Naunyn-Schmiedebergs Archiv fur experimentelle Pathologie und Pharmakologie.

[The site of N-oxidation of aniline in higher animals].

H. Uehleke, M. Kiese, 1961, Naunyn-Schmiedebergs Archiv fur experimentelle Pathologie und Pharmakologie.

Drug Mechanisms in Glaucoma, The Gilston Glaucoma Symposium. Von G. Paterson, S. J. H. Miller and G. Paterson, 320 Seiten, J. A. Churchill Ltd., London 1966. Preis: sh. 50.‐.

H. Uehleke, 1967 .

Metabolic activation of halothane and its covalent binding to liver endoplasmic proteins in vitro

K. Hellmer, H. Uehleke, S. Tabarelli-Poplawski, 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

Inhibition of microsomal drug oxidations by aliphatic halohydrocarbons: correlation with vapour pressure.

H. Uehleke, S. Poplawski-Tabarelli, 1982, Xenobiotica; the fate of foreign compounds in biological systems.

Metabolic activation of haloalkanes and tests in vitro for mutagenicity.

H. Greim, H. Uehleke, M. Krämer, 1977, Xenobiotica; the fate of foreign compounds in biological systems.

Covalent binding of haloalkanes to liver constituents, but absence of mutagenecity on bacteria in a metabolizing test system

H. Greim, H. Uehleke, M. Krämer, 1976 .

Perinatal development of tertiary amine N-oxidation and NADPH cytochrome C reduction in rat liver microsomes.

K. Hellmer, H. Uehleke, O. Reiner, 1971, Research communications in chemical pathology and pharmacology.

The oxidation-reduction potential of human haemoglobin F.

L. Flohé, H. Uehleke, 1966, Life sciences.

Trichloroethylene vapours do not produce dominant lethal mutations in male mice

H. Uehleke, R. Roll, R. Slacik-Erben, 1980, Archives of Toxicology.

Irreversible binding of 14C-labelled trichloroethylene to mice liver constituents in vivo and in vitro

H. Uehleke, S. Poplawski-Tabarelli, 1977, Archives of Toxicology.

Comparison of Serum Bilirubin Levels in Humans and Two Monogastric Animal Species After a Single Administration of Sulfisoxazole

E. Block, N. Benowitz, S. Orrenius, 1982 .

Basic requirements for long-term assays for carcinogenicity.

V. Feron, R. Peto, R. Kroes, 1980, IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans. Supplement.

Metabolic activation of haloalkanes and tests in vitro for mutagenicity.

H. Greim, H. Uehleke, Therese Werner, 1977, Xenobiotica; the fate of foreign compounds in biological systems.